The global Biopharmaceutical Excipients Market, which was valued at USD 2.7 billion in 2023, is projected to reach an impressive USD 4.17 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period from 2024 to 2031. This substantial growth is driven by the burgeoning demand for innovative drug delivery systems, increased investments in biologics production, and advancements in excipient technologies that support the stability, bioavailability, and delivery of biopharma...
more